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ABSTRACT 
STATEMENT OF PROBLEM 
“A study to assess the effectiveness of Aloe vera syrup on constipation 
among Cancer patients receiving Morphine drug in selected palliative care 
centres, at Chennai.” 
OBJECTIVES OF THE STUDY 
1. To assess the pre test level of constipation among cancer patients 
receiving morphine drug in experimental and control group. 
2. To assess the post test level of constipation among cancer patients 
receiving morphine drug in experimental and control group. 
3. To compare the pre and post test level of constipation among cancer 
patients receiving morphine drug in experimental and control group. 
4. To associate the post test level of constipation among cancer 
patients receiving morphine drug in experimental with the selected 
demographic variables. 
 MATERIAL AND METHODS 
The quantitative evaluative approach and quasi-experimental, non 
randomized control group design was selected to study the effectiveness of 
aloe vera syrup on cancer patients receiving morphine drug. 
The researcher adopted non probability convenient sampling technique 
and 60 cancer patients receiving morphine drug were selected for the study 
from RMD pain and palliative care centres at T.Nagar and Maduravayul . They 
are divided into two groups, 30 in experimental group, 30 in control group. 
The investigator used Victoria bowel performance scale which is standardized 
tool for data collection. Validity of tool was established by three experts. The 
reliability of tool was assessed by using split half method and the tool is 
considered to be reliable to proceed with main study.  
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MAJOR FINDINGS OF THE STUDY 
The findings showed that the pre test level of constipation  mean value 
in experimental group 9.06 with SD  1.60 whereas in control group mean 
value 9.59 with SD  0.94  project “t”  value as 2.58 is statistically  not 
significant at  P=0.68 level . 
The findings showed that the post level of constipation in experimental 
group was reduced to normal 20(63%).  The analysis revealed that post test 
mean value in experimental group 2.1with SD  0.4 whereas in control group 
mean value 8.24 with SD 1.52 project“ t”value as 7.3 which is statistically 
significant at  P =0.001. The study result revealed that aloe vera is effective 
in reducing constipation among cancer patients receiving morphine drug in 
experimental group. 
The study revealed that there is a significant association of post test 
level of constipation and demographic variables like habits, dietary pattern, 
and duration of consumption of morphine in experimental group. 
CONCLUSION  
Constipation is more prevalent among cancer patients receiving 
morphine drug and will decrease the quality of life. Reducing constipation 
and improving bowel movement is very important  role of a Nurse in palliative 
care unit to enhance the quality of life of patient at the end stage of life. The 
study result revealed that there was significant reduction in level of 
constipation among patient who had received Aloe Vera syrup than those who 
had not received Aloe Vera syrup. This information shows that aloe vera 
syrup is effective laxative in reducing constipation among cancer patients 
receiving morphine drug. It is cost effective and more convenient to use.    
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CHAPTER -1 
INTRODUCTION 
All's well that ends well.  
- By William Shakespeare 
Health is the wealth is an old saying, without health nothing is 
possible, As per WHO, Health is defined as "a state of complete physical, 
mental, and social well being and not merely the absence of disease or 
infirmity." 
Healthy body and mind is very important to lead a sound life in a 
natural way. Human body is like a machine, any single fault in a machine will 
result in failure in the working of machine, like that human body is build up 
of multiple organs and any small problem in a single organ will result in 
failure of its function. Problem like Headache, Nausea, Vomiting, Pain, 
Constipation, diarrhea are the symptoms of underlying disease which will 
manifest when organ function get disturbed.  
          Constipation is one of the unpleasant and distressing symptoms with 
the infrequent bowel movement result in painful defecation. Continuous 
painful defecation leads to bleeding causing anaemia and in turn affects 
psychological status of individual. Severe constipation includes failure to pass 
stool or gas and fecal impaction, can progress to bowel obstruction and 
become life threatening, often having a profound effect on their quality of 
life.  
World Gastroenterological Organization (2014) , report says that 
most of the studies estimated the prevalence of constipation in the general 
population to be 12–19%. The prevalence increases with age and is more 
frequent in females. Most persons consider constipation as a problem, yet the 
reality is that, constipation is associated with impaired quality of life, 
significant individual healthcare costs, and a large economic burden.  
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 The diet patterns, side effect of medicine, lack of exercises, unhealthy 
life style, hypothyroidism, complication of surgery are the some causes of 
constipation. 
K W Heaton, et.al, (2011) conducted a survey in Australia among 
urban people for both sex on their daily bowel habits and causes of changes in 
bowel habits, reported that life style changes and side effect of certain 
medicine were the main causes for constipation. 
 Morphine is commonly used among cancer patients in the palliative 
care set- up to control the cancer pain, to promote comfort and improve 
quality of life. Common side effect of morphine is constipation. The primary 
aim of palliative care set up will not be achieved if patients continue to have 
constipation. 
Olubunmi A Wintola, (2010) Constipation is a highly prevalent 
functional gastrointestinal disorder affecting 3-15% of the general population 
and 40-50% palliative care patients who are receiving morphine drug for 
cancer pain. In Kerala,49% of the population, consisting of both male and 
female suffer from constipation. The menace has a substantial impact on 
morbidity and quality of life which may be characterized by unexplained 
abdominal pain, discomfort and bloating in association with altered bowel 
habits.  
Nature gave immense power for all living being to lead a normal life 
with the principle of living together and sharing with each other. In olden 
days there was no multi specialty hospital and no specialization like present 
scenario in medical field. Our ancestors led a normal and healthy life by using 
many natural products. Aloe Vera is one among them that has many healing 
properties used for many ailments. Many studies proved that Aloe Vera is one 
of best laxative which relieves constipation. 
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ALOE VERA 
Bhaskaranaidu, (2000 BC) Aloe Vera is a stem less plant growing to 
60-100cm tall, spreading by offsets .Aloe Vera is commonly called by various 
names as lily of desert,burn plant,foundation of youth, healing plant, 
elephant‟s  gallets.In India it is called ghrit. Aloe vera use goes back to over 
6000 years in Egypt. Egyptians buried dead pharaohs along with Aloe vera as 
they considered it “ a plant of immortality.‟ They still grow Aloe vera around 
graveyards. 
Dhanvantri, (5000BC) In India Rig Veda is the earliest Ayurvedic 
book of natural medicine in about 5000BC. Rig Veda recommends Aloe vera 
for treating disorders of reproductive system and liver,worm infestation and 
healing of external wounds, disorder of gastro intestinal problem. 
           In  India, it is often called the “miracle plant” and is the oldest known 
and most used medicinal plant. The leaves are thick and fleshy, Aloe vera 
leaves contains photochemical such as acetylated mannans, polymannans, 
anthraquinone C-glycosides. It has about 200 active ingredients which have 
been proved scientifically and numerous combinations of these ingredients 
ensure a broad spectrum of activity against disorders in human being. 
Meika Foster, (2011) chemical analysis showed that aloe vera 
consists of  as much as 75 nutrients, 20 minerals, 12 vitamins, 18 amino acids 
and 200 active enzymes. Aloe vera contains Vitamin A, B1, B2, B6 and B12, 
Vitamin C and E, folic acid and Niacin. Minerals found in aloe vera include 
copper,iron,glycosides,sodium,calcium,zinc,potassium,chromium, magnesium 
and manganese. The nutrients naturally present in aloe vera makes it a 
potential herbal product that can be safely used both internally and externally. 
This exotic plant contains other beneficial compounds like polysaccharides, 
mannans, anthraquinones and lectins. The presence of these makes it possible 
to use aloe vera for variety of therapeutic purposes.  
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Champman and Pittelli, (2009) done double-blind, randomized, 
controlled trial on 28 healthy adult reported that aloe vera had laxative effect 
compared to a placebo which was stronger than stimulant laxative 
phenolphthalein. 
Odes and Madar, (2009) conducted double blind trial on subject with 
constipation and he administered novel preparation containing aloe vera, 
celandine, and psyllium. This study reported that bowel movement has been 
improved after administration of novel preparation containing alove vera, 
celandine and psylium.Thus he concluded that aloe vera was effective laxative 
in relieving constipation.  
Aloe vera laxative preparations have been approved by the German 
Commission E governmental regulatory agency  for use in the treatment of 
constipation as a second-line agent. 
Heber, (2010) retrospective study proved that Aloe vera has a long 
history of popular and traditional use. It is used in traditional Indian medicine 
for constipation, colic, skin diseases, worm infestation, and infections . 
NEED FOR STUDY 
Constipation is the most common problem among cancer patients 
receiving morphine in the palliative care set up. As per World health 
organization, 2009  Palliative care is an approach that improves the quality 
of life of patients and their families facing the problem associated with life -
threatening illness, through the prevention and relief of suffering by means of 
early identification and impeccable assessment and treatment of pain and 
other problems, associated with  physical, psychosocial and spiritual well 
being. 
Chronically ill patients have no opportunity of having curative 
treatment but will be admitted in the palliative care centre in order to be 
comfortable and improve the quality of life during their stage of life. 
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Cancer is the one of the chronic disease.  The term “cancer” is the most 
feared and burdensome word to the patient as well as to their family. Cancer 
pain is multifocal and dynamic and, if not treated adequately, the 
consequences are devastating.  
Lyon/Geneva, 2013,The Agency for Research on Cancer (IARC- 
International agency for research on cancer), is a specialized cancer agency of 
the World Health Organization, released the latest data on cancer incidence, 
mortality, and prevalence worldwide.  
Global burden rises to 14.1 million new cases and 8.2 million cancer 
deaths in 2012.In India it is estimated that there are 2 to 2.5 million cancer 
patients at any given point of time with 0.7 million new cases  every year and 
nearly half of them die in each year. 55,000 new cancer cases  are observed 
per year in Tamil Nadu. The total cancer burden in Chennai is predicted to 
increase by 32 per cent in 2012-2016; Breast cancer would also dislodge 
cervical cancer as the top-ranking cancer in the State. 
   In Cancer, Pain is most common and intolerable one. Up to two-third 
of people with cancer experiences pain and that pain is subjective feeling.  It 
is most important to control it in order to enhance the quality of life at the end 
stage of life. But cancer pain needs a strong opioids . 
National institute for Health and clinical excellence (2012)  
revealed that strong opioids, especially morphine, are the principal treatments 
for pain related to advanced and progressive disease, and their use has 
increased significantly in the primary care setting. However, the 
pharmacokinetics of the various opioids are very different and there are 
marked differences in bioavailability, metabolism and response among 
patients. Morphine is primarily used to treat both acute and chronic severe 
pain. Like other opioid morphine will act on central nervous system and 
reduce pain.  
International Narcotic Control Board (2014)reported that 
Globally 6.11 mg/ capita of morphine, In India 0.2651 mg/capita of morphine 
are being used yearly for various purpose.  
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Indian Narcotic Control Board (2014)stated that out of  0.2651 
mg/capita , nationally0.2001 mg/capita, 0.662 mg/capita in Tamilnadu and 
0.540 mg/capita in Chennai are exclusively used for cancer pain 
World Health organization 2013, globally, estimated that a total of 
365 million prescriptions were written for opioids in which 235 million 
prescriptions in the USA, 66 million in the EU and 64 million in the rest of 
the world .A substantial proportion of these prescriptions were written for 
cancer pain in India about10 million  and 1million for Tamilnadu. 
 
Table -1.1: WHO (bulletin) 2014 Statistics on cancer, Morphine use,                        
                 Morphine induced constipation. 
 
S. 
No 
Distribution 
Number of 
cancer cases 
per year 
Amount of 
morphine use per 
year  percapita 
Number of 
morphine 
induced 
constipation in 
million. 
1 Global 14.1million 6.11 mg/capita 7million 
2 India 2-2-5million 0.211 mg/capita 1.7 million 
3 Tamilnadu 55 000 0.066mg/capita 0.22million 
4 Chennai 16718 0.050 mg/capita 0.15million 
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Fig- 1.1: WHO (Press)2014 Statistic on morphine induced 
Constipation among cancer patients 
 
Bussia, (2010) in his study he found that oral morphine remains the 
cornerstone of cancer pain management. In 20–30% of cancer patients, pain is 
present in the early stage of disease, and the figure goes beyond 70–80% in 
advanced stages of cancer. Although most of the patients get adequate pain 
relief with opioid, a minority of patients treated with oral morphine (10–30%) 
do not have a successful outcome because of excessive adverse  effects, 
inadequate analgesia,or combination of both.  
No medicine is without side effect, the most common adverse effect of 
morphine is constipation. Possible etiologies of opioid induced constipation 
include increased anal sphincter tone, reduced peristalsis in  the small intestine 
and colon,increased electrolyte and water absorption, and impaired defecation 
response. The µ and delta, are the two receptors, Which are located on gut 
smooth muscle and have the largest role in gastrointestinal motility, with µ 
directly affecting the myenteric plexus.  
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Two phases of Peristalsis, contraction and relaxation. Acetylcholine 
mediates contraction, and vasoactive peptide mediates relaxation. Whereas 
anticholinergic drugs constipate by inhibiting contraction,opioids may 
modulate both components contraction and relaxation. Opioid receptor 
involvement in mediation of acetylcholine and vasoactive peptide is not 
strictly a local action on the gastrointestinal tract, as parenteral opioids also 
reduce gut transit time.  
Normal defecation occurs under control of receptors in the upper anal 
canal, which detect stool, and the internal anal sphincter. Exogenous opioids 
inhibit not only detection but also relaxation of the internal anal sphincter. 
Perhaps not a direct etiology of opioid-induced constipation, this physiologic 
mechanism may play an important role in overall symptoms.   
John Meckerly ,(2012) had done study on side effect of opioid, he  
assessed 593 cancer patients receiving opioid treatment according to WHO 
guidelines. He found that constipation was one of the most frequent side 
effects of opioid treatment, observed in 23% of patients. Another series of 
studies conducted in a large US hospice found that 40–63% of patients with 
cancer had opioid-induced constipation (OIC). The higher rate (63%) was 
derived from retrospective patient reports and the lower rate corresponded to 
data obtained from a chart audit (40%). 
 15% to 90% of patients receiving opioids develop constipation. 
Current treatment for opioid induced constipation, which includes laxatives, 
stool softeners and if necessary, reflex evacuation via enema  is distinctly 
sub-optimal with up to 46% of patients not achieving the desired treatment 
outcome. 
Culpepper Morgan, (2011) study showed that there has been a rapid 
increase in patients experiencing OIC(opioid induced constipation) , with 
approximately 40-50% of chronic opioid users reporting symptoms. 
Traditionally, constipation has been treated with laxatives based on empirical 
research. However, the efficacy of laxatives to treat OIC is relatively poor 
and only provides adequate relief for approximately 50% of patients. Prior to 
2011, the OIC market was desolate, with no approved pharmaceutical (non-
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laxative) treatment for this condition. There is currently a paucity of approved 
products, with heavy restrictions limiting their use for the majority of OIC 
sufferers.  
When the investigator had been working in the clinical area had the 
opportunity to take care the cancer patient with constipation problem that 
motivated the investigator to select this study.  
1.2. STATEMENT OF THE PROBLEM 
“A study to assess the effectiveness of Aloe vera syrup on constipation 
among Cancer patients receiving Morphine drug in selected palliative care 
centres, at Chennai.” 
1.3. OBJECTIVES OF THE STUDY 
1) To assess the pre test level of constipation among cancer patients  
receiving morphine drug in experimental and control group. 
2) To assess the post test level of constipation among cancer patients 
receiving morphine drug in experimental and control group. 
3)      To compare the pre and post level of constipation among cancer   
          Patients receiving morphine drug   in experimental and control group. 
4)      To associate the post test level of constipation among cancer patients     
receiving morphine drug in experimental group with the selected 
demographics variables. 
1.4. OPERATIONAL DEFINITION 
Effectiveness: In this study it refers significant improvement in 
softness of stool and bowel movement after administration of Aloe Vera 
syrup.  
Aloe Vera Syrup: it refers to commercially prepared syrup, dosage is 
30 ml once a day before breakfast in an empty stomach for 3 days. 
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Constipation: it refers hard stool and infrequent bowel movement due 
to morphine and score value of -2 and -3 of Victoria bowel performance scale.  
 Cancer patients: Male and female at the age group of 36-55 years 
with diagnosis of cancer who are receiving morphine drug.  
Morphine drug:  30 mg tablet orally in divided doses daily to control 
cancer pain. 
Selected Palliative Care Centre: RMD Pain and Palliative Care 
centres, which are  registered centres at T. Nagar and Madhuravayul, Chennai.   
1.5. RESEARCH HYPOTHESES 
H1: There is a significant difference between the pre-test and post-
test level of constipation among cancer patients receiving 
morphine drug in experimental and control group.   
H2: There is a significant association in the post test level of 
constipation in experimental group among cancer Patients 
receiving morphine drug with the selected demographic 
variables. 
1.6. ASSUMPTIONS 
1) Constipation will be prevalent among cancer patients receiving  
morphine drug.   
2) Aloe Vera syrup will improve the bowel movement.  
1.7. DELIMITATION 
 The study is limited to four weeks. 
 The study is limited only to cancer patients receiving morphine drug at 
RMD pain and palliative care centres at Chennai. 
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CHAPTER- 2 
2.1 REVIEW OF LITERATURE 
Review of literature provides for a basis for future investigation. It 
justifies the need for replication, throws light on the feasibility of the study. It 
also reveals constraints of data collection and relates the findings from one 
study to another with a view to establish a comprehensive body of scientific 
knowledge in a professional discipline from which valid and pertinent 
theories may be developed. 
The sources to obtain more information on the selected topic were from 
book, Medline search, Published Journals and unpublished thesis.  
The review of literature has been presented under following headings.  
Section-A: Literature related to Morphine use in Cancer Patients”.  
Section-C: Literature related to morphine induced constipation”.  
Section-B: Literature related to effectiveness of Aloe Vera”.   
SECTION-A:  LITERATURE RELATED TO MORPHINE USE 
IN CANCER PATIENTS  
     Bruera E et.al,(2014) had conducted a study to compare the 
effectiveness and side effects of methadone and morphine as first -line 
treatment with opioids for cancer pain. He randomly assigned 103 patients in 
international palliative care clinics with pain requiring initiation of strong 
opioids  to receive methadone (7.5 mg orally every 12 hours and 5 mg every 4 
hours as needed) or morphine (15 mg sustained release every 12 hours and 5 
mg every 4 hours as needed). The study duration was 4 weeks. A total of 103 
patients were randomly assigned to treatment (49 in the methadone group and 
54 in the morphine group).   The opioid escalation index at days 14 and 28 
was similar between the two groups. The proportion of patients with a 20% or 
more improvement in pain at 4 weeks in the methadone group was 0.49 (95% 
CI, 0.34 to 0.64) and was similar in the morphine group (0.56; 95% CI,  0.41 
to 0.70).  He concluded in his study that Methadone did not produce superior 
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analgesic efficiency or overall tolerability at 4 weeks compared with 
morphine as a first-line strong opioid for the treatment of cancer pain.                                                                 
Højsted J Sjøgren P, (2013) aimed at giving an overview of 
definitions, mechanisms, diagnostic criteria, incidence and prevalence of 
addiction in opioid treated pain patients. He reviewed many screening tools 
for assessing opioid addiction in chronic pain patients and tried to provide 
recommendations regarding addiction problems in national and international 
guidelines. The review indicates that the prevalence of addiction varied from 
0% up to 50% in chronic non-malignant pain patients, and from 0% to 7.7% in 
cancer patients depending on the subpopulation studied and the criteria used. 
He identified several screening tools, but only a few were thoroughly 
validated with respect to validity and reliability. Most of the identified 
guidelines mention addiction as a potential problem 
S Mercadante et .al, (2013) conducted prospective randomized study 
in a sample of 40 patients with advanced cancer who required strong opioids  
for their pain management. He calculated opioid escalation indices in 
percentage (OEI %) and milligrams (OEI). The effective analgesic score 
(EAS) that monitors the analgesic consumption-pain ratio was also calculated 
at fixed weekly interval. Patients treated with methadone reported values of 
OEI significantly less than those observed in patients treated with morphine.  
His study reported that Morphine is a drug of indisputable value in the 
treatment of cancer pain, and an unbalanced focus on the risks of 
inappropriate use rather than the benefits should not compromise the use of a 
relevant alternative to methodone in the management of cancer pain.  
Yusy et.al,(2012) evaluated the effect and adverse effects 
of morphine hydrochloric sustained release for patients with cancer pain. He 
selected a total of 567 patients, 369 males (65.1%) and 198 females (34.9%), 
aged 65 - 90 with a mean age of 72.6. initial dosage was 30 mg every 12 
hours, He asked all patients to record the attacks of pain, quality of life, and 
any side effect of the treatment.  His study reported the common side effects 
were constipation (14.3%), nausea (13.4%), dizziness (3.4%), vomiting 
(2.8%), drowsiness (0.7%), dysuria (0.4%), mental symptoms (0.2%), and 
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respiratory depression (0.2%). He concluded in his study that oral treatment 
with sustained release morphine hydrochloride for patients with cancer pain is 
effective, safe, and convenient, and can improve the quality of life.  
Ranchere JY et .al,(2012) conducted a study in a 230 comprehensive 
beds Cancer Centre, on 129 patients, randomized between all the patients 
hospitalized. He used open questionnaire and studied different aspects.  His 
study concluded that explanation before treatment was very effective which 
enable patient to identify side effect and report any adverse  effect of 
treatment. Most patient reported constipation was common side effect (30%). 
For 14 patients there was no problem and 2 not aware of it.  
        Manzini JL et .al, (2012) carried out retrospective study on the 
effect of morphine among 40 patients who had received the drug for more 
than three consecutive days in Assam. The ambulatory patients represented 
27.5% of the sample. The average initial dose was 60 mg, and the average 
maintenance dose was 120 mg. The median treatment time was 45 days. His 
study concluded “good" results were achieved in 85% of the patients, and 
"fairly good" in the remainder  and reported that more frequently treated 
symptoms were: -67.5% of pain due to tumor mass and 20% of  pain due to 
nerve compression invasion, bone pain, and dyspnoea due to pulmonary 
metastases or primary lung cancer.  
SECTION – B: LITERATURE RELATED TO MORPHINE 
INDUCED CONSTIPATION  
A Kamuhabwa D, Ezekiel, (2013) Assessed the rational use and 
effectiveness of morphine for management of pain. He interviewed a total of 
100 cancer patients receiving morphine therapy at the inpatients in Tanzania 
and seven (7) palliative caregivers, including two doctors, two nurses, a 
pharmacist, a pharmaceutical technician and a social worker were also 
interviewed. Of the 100 interviewees, 37% were aware of morphine.  His 
study results showed that oral morphine solution was the most common route 
(96%) of administration. Although most patients (79%) experienced 
morphine-induced side effects, the majority (93%) were continuing with the 
therapy. For both outpatients and inpatients the common side effect was 
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constipation 69%. His study concluded that the use of morphine was effective 
to relieve pain but has the adverse effect of constipation. 
Latasch L et. al,(2013) studied effect of naloxone on opioid  induced 
constipation on fifteen cancer patients receiving morphine. Constipation had 
been present for 5 to 14 days despite the use of laxatives.  Naloxone 
administered at a dose ratio of 1:1 with respect to morphine on day 1 and 2.  
Average loss of 10%-15% of analgesia after oral naloxone as measured by 
visual analogue scales. Increasing the morphine dose by about 15% restored 
the previous level of analgesia without reappearance of constipation. His 
study concluded that the treatment of opioid-induced constipation by 
administration of oral naloxone produced positive results.  
Leppert W et. al,(2012) assessed effectiveness of Methylnaltrexone 0n 
Opioid-induced constipation. MNTX demonstrates significant superiority over 
placebo. Another product is combination of oral formulation of prolonged 
release oxycodone and prolonged release naloxone (PR oxycodone/PR 
naloxone), indicated for patients who require opioid administration for 
chronic pain and have already developed OIC, and for those who need opioid 
therapy and take the drug to prevent OIC. Naloxone administered orally 
displays local, antagonist effects on opioid receptors in the gut wall, 
negligible systemic bioavailability, and significantly reduces the oxycodone 
constipating effect. His study concluded that  PR oxycodone/PR naloxone has 
similar analgesic efficacy, but causes less constipation and less laxative 
consumption in comparison with patients treated with oxycodone alone.       
G Andersen et .al, (2011), assessed forty-two cancer patients treated 
with oral sustained-release (SR) morphine for pain, sedation and other side 
effects related to morphine treatment. Blood samples were analysed for 
morphine, M-3-G (Morphine -3- glucuronide) and M-6-G (Morphine – 6- 
glucuronide)by high-performance liquid chromatography (HPLC). His study 
reported 79% of the patients suffered from dryness of the mouth, which was 
the most frequent side effect observed. Patients in this group had higher 
plasma morphine and M-6-G concentrations than patients who did not suffer 
from this side effect. 
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Schmerz et. al ,(2012)  assessed adverse effect of opioid therapy.  The 
most frequent and persistent side effect in the course of opioid treatment is 
constipation. It is mainly caused by linkage of the opioid to the peripheral 
mu-receptors in the bowel and may increase as a result of certain concomitant 
circumstances, such as poor intake of fluids or electrolyte disorder. His study 
reported that there is a relation between type of opioid and degree of 
constipation. 
Peter Holzer et. al,(2010) Double- blind, randomized and placebo-
controlled trials reported that peripheral opioid receptor antagonists (PORAs) 
counteract OIC. Subcutaneous methylnaltrexone for the interruption of OIC in 
patients with advanced illness, and a fixed combination of oral prolonged-
release naloxone with prolonged-release oxycodone for the prevention of OIC 
in the treatment of non-cancer and cancer pain. Both drugs counteract OIC 
and also  more than 50 % of the patients with constipation under opioid 
therapy may benefit from the use of PORAs, while PORA-resistant patients 
are likely to suffer from non-opioid-induced constipation.  
SECTION-C: LITERATURE RELATED TO EFFECTIVENESS 
OF ALOE VERA 
A O T Ashafa et .al ,(2013) evaluated the efficacy of the ethanolic leaf 
extract of Aloe Vera  against loperamide –induced constipation among 
diarrhea patients in Victoria hospital Canada. Two group experimental group 
and control group consist of 50 in each,  one group were treated with 50, 100, 
and 200 mg/kg body weight/day of the ethanolic leaf extract for 7 days during 
which the feeding characteristics, body weight, fecal properties, and 
gastrointestinal transit ratio were monitored. His study reported that intestinal 
motility improved, increased fecal volume, and normalized body weight in  the 
constipated patients. His study findings have therefore lent scientific support 
to the use of the herb as a laxative agent in Nigerian folkloric medicine. 
Richard Phillip et.al,(2013) studied effect of aloe vera on constipation. 
Two groups of 15 each. The test group was fed specified doses of Aloe vera 
daily, utilizing this as the sole liquid constituent for its diet. The control 
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group was fed water as the sole liquid constituent of its diet, After the three 
days period, he examined bowel of each individual in the test groups.  His 
study result reported the bowel of the test group (fed large quantities of Aloe 
vera its exclusive liquid constituent) had 85% normal bowel movement than 
the group that consumed water alone. His study concluded that aloe vera was 
effective in relieving constipation.       
Wintola et .al, (2012) studied the efficacy of aqueous leaf extract of 
Aloe ferox Mill against the loperamide –induced constipation. In his study the 
control group  received  only routine care and the experimental group  were 
treated with 20, 50 and 100 mg/kg body weight/day of the extract for 7 days 
during the period he monitored the feeding characteristics, body weight, fecal 
properties and gastrointestinal transit ratio. Result shows the extract improved 
intestinal motility, increased fecal volume and normalized body weight in 
experimental group. His study concluded that aloe vera was effective laxative. 
Zhong et .al, (2013) evaluated the effectiveness of polysaccharides 
from Aloe Vera against gastric ulcer induced by water impression stress. 80 
sample- 40 experimental, 40 control group. He administered aloe vera for 7 
days. Stress scale was used. His study concluded that aloe vera was effective 
in reducing stress.  
Ramesh PR et .al,(2013) Conducted a study on control trial comparing 
a liquid herbal preparation misrakasneham (aloe vera) with a conventional 
laxative tablets (sofsena) on opioid induced constipation patients with 
advanced cancer. He found statistically  no significant difference in degree of 
laxative action between the two, the result  of his study  indicates that the 
small volume of the drug required for effective laxative action  ,the tolerable 
taste , the once daily dose , the acceptable side effect profile , and the low 
cost make Misrakasneham a good choice for prophylaxis opioid induced 
constipation. 
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2.2 CONCEPTUAL FRAMEWORK  
A conceptual framework is a net work of interrelated concepts that 
provide a structure for organising and describing the phenomenon of interest. 
It deals with abstraction (concepts) which are assembled together by virtue of 
their life relevance to a common theme. 
The researcher adopted the conceptual framework based on Modified 
LudwigVon Bertalanffy‟s General System theory. In general system theory, 
the system is composed of both structural and functional components that 
interact within the boundary, which filter the type and rate of exchange with 
the environment. A structure refers to the arrangement of the part at a given 
time whereas function is the process of continuous change in the system as  
matter, energy and information. 
For survival a system must achieve a balance internally and externally. 
Equilibrium depends on the the system ability to regulate input and output to 
achieve a balanced relation of the interactive part and the process applied for 
proper balance. 
The system uses various adaptation mechanisms to maintain equilibrium. 
Adaptation may occur through accepting or rejecting the matter, energy and 
information or accommodating the input or modifying the system. 
Ludwig Von Bertalanffy‟s General system theory focuses on the following  
 Input 
 Through put 
 Output 
INPUT 
According to general system the input refers to the matter, energy or 
information from the environment into the system. Here the input includes 
subject age, sex, education, occupation, and religion, duration of morphine 
consumption, fluid intake, and bowel habits. Victoria bowel performance 
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scale used to assess the pre test level of constipation in experimental and 
control group. 
THROUGHPUT 
In this model throughput refers to the procedure by which matter, 
energy and information are modified or transformed within the system. In 
present study it include administration of aloe Vera syrup to cancer patients 
receiving morphine drug in experimental group and routine care (Duphalac 
syrup) to control group 
OUTPUT 
Output refers to matter, energy and information that are released into 
the environment. In present study it involves post assessment of level of 
constipation in experimental and control group by using Victoria bowel 
performance scale. Output was  decreased level of constipation , increased 
bowel movement, softness of stool in experimental group and  decreased 
bowel movement, and hardness of stool, constipation not relieved in control 
group.
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CHAPTER-3 
RESEARCH METHODOLOGY 
 
INTRODUCTION 
In this chapter it includes research design, study setting, variables, 
population, sample size, sampling technique and sample selection criteria, 
description of the tool, content validity, pilot study, reliability and method of 
data collection and data analysis procedure. 
3.1 RESEARCH APPROACH 
Research approach adopted in this study is Quantitative evaluative 
research approach. 
3.2 RESEARCH DESIGN 
Research design adopted for this study is quasi experimental design. 
The research design is represented diagrammatically as follow 
GROUP 
PRE 
ASSESSMENT 
INTERVENTION 
POST 
ASSESSMENT 
Experimental 
Group 
O1 X O2 
Control Group O1  O2 
           O1   –      pre assessment 
          X      -    Administration of aloe vera syrup   
           O2      -       post assessment 
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In this study pre assessment level of constipation of experimental and 
control group were measured by using Victoria bowel performance scale 
followed by administration of aloe vera syrup 30 ml for 3 days before 
breakfast in an empty stomach to experimental group. At the end of 
intervention period the post assessment level of constipation were assessed in 
experimental and control group by using Victoria bowel performance scale. 
3.3 VARIABLES 
Independent Variables    
Aloe Vera Syrup 
Dependent Variables   
Constipation  
3.4 SETTING OF THE STUDY 
The study was conducted at RMD Pain and Palliative care centres at 
T.Nagar and Maduravayul in Chennai. Pain and palliative care centres, are 
registered centres headed by Dr.Republica Sridhar M.B.B.S, F.C.C.P., She is 
a palliative geriatric care specialist. RMD has two branches one at T.Nagar 
and other at Maduravoyul has total strength of 150 beds that provides pain 
relief and palliative care to terminally ill patients and family. RMD provides 
service for inpatient, outpatient, home service, community care, counselling, 
education, hospice care, Moksha and community based palliative care. The 
average monthly admission in RMD Pain and Palliative care trust at T.Nagar 
centre is 50 and at Maduravayul centre is 60. 
3.5 POPULATION  
Population of the study includes all cancer patients receiving morphine 
drug admitted in palliative care centres. 
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3.6 SAMPLE 
The study sample comprises cancer patients receiving morphine drug 
who fulfilled the inclusion criteria. 
3.7 SAMPLE SIZE 
The sample size for study was 60 cancer patients receiving morphine 
drug who fulfilled inclusion criteria out of which 30 patients belongs to 
experimental group and 30 patients belongs to control group.  
3.8 SAMPLE SELECTION CRITERIA 
The researcher specified certain inclusion and exclusion characteristics 
for the population to be considered as a sample. Accordingly the population is 
studied and those that come under inclusion characteristics are selected as the 
sample and the other elements are excluded from the study. The criteria are as 
follows 
INCLUSION CRITERIA  
Study included cancer patients receiving morphine drug and come 
under the following inclusion criteria.  
1. Age group of 36 to 55 years, Male and Female. 
2. Cancer  patient receiving morphine drug 30 mg in divided doses for 
thrice a day. 
3. Able to understand Tamil and English.  
4. Willing to participate. 
5. Stay in the centre more than three days.  
EXCLUSION CRITERIA  
Study excluded cancer patients receiving morphine drugs with below criteria 
1. Heart and renal disease and GI cancer.  
2. The patient who had undergone GI surgery.  
3. Patients who are undergoing diuretic treatment  
3.9 SAMPLING TECHNIQUE 
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The subjects of present study were selected by non probability 
convenient sampling technique. 
3.10 DEVELOPMENT OF THE TOOL  
The researcher developed the tool on the basis of objectives of the 
study. The following steps were adopted prior to the development of the tool. 
Review of literature provided adequate content for the tool preparation, 
personal experience of the researcher in the clinical field and opinion from 
the experts  from  Medical and Surgical Nursing  that helped in devising the 
tool. 
The Tool was developed in English and translated into Tamil. 
Congruency was maintained after translation.  
3.11 DESCRIPTION OF THE TOOLS 
The tool consists of two parts:  Part-1 and Part-2.  
Part-1: Demographic Data 
This part of tool consist of 14 items for obtaining information about 
the selected background factors such as age, sex, religion, education, marital 
status, occupation, dietary pattern, bowel habits, fluid intake, duration of 
morphine consumption, support system, and type of family.  
Part-2: Victoria Bowel Performance Scale 
Victoria Bowel Performance Scale consists of 24 items. Each defined 
by series of symptoms.  
VICTORY BOWEL PERFORMANCE SCALE 
The scale used was a standardized Victoria bowel performance scale. 
The Victoria bowel performance scale was used to assess the pre test level of 
diarrhoea and constipation in order to make sure the selected sample were 
only constipated patients for the study, which has 3 components: 
1. Characteristics  
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2. Pattern 
3. Control  
SCORE INTERPRETATION 
-1,0,+1  - Normal bowel movements  
 +2 - Mild diarrhoea 
 +3 - Moderate diarrhoea 
 +4 - Severe diarrhoea 
 -2 - Mild constipation 
 -3 - Moderate constipation 
 -4 - Severe constipation 
3.12. ETHICAL CONSIDERATION   
The study was conducted after getting the approval from ethics 
committee of Venkateswara Nursing College, Thalambur , Chennai, and  
permission was obtained from Medical director, R M D Pain and Palliative 
care centres at Chennai -6000017. Informed consent was obtained from each 
study participant after giving full information about the study. Confidentiality 
was assured to each participant and maintained by the researcher . 
3.13 TESTING OF TOOL 
The content validity of tool was confirmed on the basis of opinion from 
two experts. 
3.13.1 CONTENT VALIDITY 
The tool was submitted to Medical director and two experts of Medical 
and Surgical Nursing. Experts were asked to give their opinions and 
suggestions about content of the tool. Needed modifications were 
incorporated in the final preparation of tool.  
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3.13.2 RELIABILITY 
Reliability of the tool was tested by split half method. The test was 
divided into equivalent halves and reliability was found for bowel 
performance scale. The reliability of the tool was 0.79 and hence the tool was 
found to be reliable for proceeding with the main study. 
3.13.3 PILOT STUDY 
Pilot study was a small scale version, trial run for major study to test 
the reliability, feasibility, practicability, appropriateness and flexibility of the 
tool for the study. 
Prior permission to conduct the study was obtained from Medical 
director of R M D Pain and palliative care centres at Chennai. The 
investigator conducted a pilot study at RMD Pain and Palliative care centres, 
at T.Nagar and at Maduravayul in Chennai.  Patients at T.Nagar were used as 
a experimental group and at Maduravoyul used as a control group.  Cancer 
patients receiving morphine drug who fulfilled the inclusion criteria were 
selected (control group -3 and experimental group -3) by non probability 
convenient sampling technique. The purpose of this study was explained to 
subjects and written consent was obtained from the patients. Confidentiality 
was assured to all patients. Data was collected from 31 / 3/ 14 to 6/ 4/ 14. 
The demographic variables were obtained with the help of questionnaire 
and data on level of constipation was obtained through Victoria bowel 
performance scale. With the prescription of palliative care unit head, the 
investigator administered aloe vera syrup to each patient before food in an empty 
stomach 30ml for 3 days.The level of constipation was assessed on 3
rd
 day by 
using Victoria bowel performance scale. 
The data was analysed using descriptive statistics that is percentage, 
mean and standard deviation of variables calculated and compared. Result 
revealed that in experimental group the level of constipation was reduced to 
mild and normal.  The tool found feasible and practicable. No further changes 
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were made after pilot study in the tool. The investigator proceeded for the 
main study. 
3.14 DATA COLLECTION PROCEDURE 
A written permission was obtained to conduct the study from the ethics 
committee of Venkateswara Nursing College, Thalambur, Chennai – 600130 
and the formal permission was obtained from the Medical Director of the 
RMD Pain and Palliative care centres at T.Nagar, Chennai. Data collection 
carried out for 4 weeks.  
 Before starting the study the investigator identified the subjects from 
the case record and those cancer patients receiving morphine drug developed 
constipation and fulfilled inclusion criteria were selected. Purpose of study 
was explained to sample, confidentiality of the subject was assured and 
consent was obtained from the sample. Using Part - 1 of the Tool, 
demographic data of cancer patients receiving morphine drug were collected 
from the patients admitted in RMD pain and palliative care centres.  
Pre assessment level of constipation in experimental and control group 
were assessed using Victoria bowel performance scale. With the prescription 
of palliative care unit head of RMD pain and palliative care centres each 
patient in experimental group was administered aloe vera syrup 30 ml for 3 
days before breakfast in an empty stomach orally. Every day assessment was 
carried out.  The post assessment level of constipation was assessed in 
experimental and control group on 3
rd
 day of administration of aloe vera 
syrup by Victoria bowel performance scale.  Only on 3
rd
 day assessment was 
taken for data analysis to determine the effectiveness of aloe vera syrup in 
relieving constipation among cancer patients receiving morphine drug in 
experimental group.  Each day 6-7 samples were administered aloe vera 
syrup. The collection of data was performed within the stipulated time of 4 
weeks.  
3.15 DATA ANALYSIS PROCEDURE 
Data was planned to be analysed on the basis of objectives and testing 
of hypotheses by using descriptive and inferential statistic.  
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Descriptive statistics 
Descriptive statistic was used to analyze the frequency, percentage, 
mean, and standard deviation of the following variables.  
1. Frequency and percentage of demographics data was assessed. 
2. Frequency, percentage, mean and standard deviation were used to 
assess the level of constipation of experimental and control group. 
Inferential statistics 
Inferential statistics were used to determine the relationship, 
association and comparison to identify the differences.  
Paired `t‟ test and unpaired “t” test were used to compare the pre test 
and post test level of constipation in experimental and control group before 
and after administration of Aloe Vera syrup. 
Chi –square test was used to find out the association of demographic 
variables on level of constipation in experimental group. 
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CHAPTER- 4 
DATA ANALYSISANDINTERPRETATION 
 
DATA ANALYSIS AND INTERPRETATION 
The chapter deals with analysis and interpretation of data collected 
from 60 cancer patients receiving morphine drug to find out effectiveness of 
aloe vera syrup on constipation in selected palliative care centres.  
ORGANISATION OF DATA: 
The data collected were analysed, tabulated, interpreted and findings were 
presented in the form of tables and diagrams under the following sections  
 
Section – A: 
Assessment of demographic variables in experimental group and 
control group of cancer patients receiving morphine drug. 
Section – B: 
Assessment of pre test level of constipation in experimental group and 
control group. 
Section – C: 
Assessment of post test level of constipation in experimental and 
control group.     
Section – D: 
Comparison of pre and post test level of constipation in experimental 
and control group. 
Section – E: 
Association of post test level of constipation in experimental  group 
with the selected demographic variables  
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SECTION A: ASSESSMENT OF DEMOGRAPHIC VARIABLES OF 
CANCER PATIENTS RECEIVING MORPHINE DRUG IN 
EXPERIMENTAL AND CONTROL GROUP 
Table 4.1: Frequency and percentage distribution of demographic     
                 variables of cancer patients receiving morphine drug in  
               experimental and control  group.   
N =30+30                               
 
Demographic variables 
Group 
Experimental Control 
n % n % 
Age  36-40 
41-45 
46-50 
51-55 
2 
9 
15 
4 
9.7% 
32.3% 
48.7% 
9.3% 
3 
10 
14 
2 
11.3% 
37.7% 
46% 
5% 
Gender  Male  
Female  
14 
16 
 
46.7% 
53.3% 
 
15 
15 
 
50% 
50% 
 
Religion  Hindu  
Muslim  
Christian  
 Other  
13 
13 
4 
0 
 
43.3% 
43.3% 
13.3% 
0 
 
18 
8 
4 
0 
 
60% 
26.7% 
13.3% 
0 
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Demographic variables 
Group 
Experimental Control 
n % n % 
Education  
 
 
 
Illiterate 
Primary 
school 
High school 
Higher 
secondary 
school 
Graduate 
1 
   10 
 
11 
 
6 
 
2 
 
3.3% 
33.3% 
 
36.7% 
 
20.0% 
 
6.7% 
 
3 
13 
 
11 
 
2 
 
1 
 
9% 
42.3% 
 
39% 
 
6% 
 
3% 
Regarding age 2(9.7%) were in the age group of 36-40, 9(32.3%) were 
in the age group of 41-45, 15(48.7) were in the age group of 46-50 and 4(9.3) 
were in the age group of 51-55 in experimental group. In control group 
3(11.3%) were in the age group of 36-40, 10(37.7%) were in the age group of 
41-45, 14(46%) were in the age group of 46-50 and 2(5%) were in the age 
group of 51-55.Majority were in the age group of 46-50 in both the group.  
Considering sex 14(46.7%) were male in experimental group, 15(50%) 
were male in control group,16 (53.3%) were female in experimental group, 
15(50%) were female in control group.  
Regarding religion 13(43.3%) were Hindu 13(43.3%) were Muslim and 
4(13.3) were Christian in experimental group and 18(60%) were Hindu, 8(26.7)  
were Muslim and 4(13.3%) were Christian in control group. Majority were in 
Hindu religion in both group. 
Considering education 1(3.3%) was illiterate, 10(33.3%) were primary 
level,6(20%) were secondary school level and  2(6.7) were  graduate level in 
experimental group. 3(9%) were illiterate, 13(42.3) were primary level, 
11(39%) were high school level,2(6%) were secondary school level and  
1(3%) was  graduate level in control group. 
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Figure 4.1: Distribution of age of cancer patients receiving morphine     
drug 
 
 
Figure 4.2:  Distribution of Sex of cancer patients receiving morphine drug 
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Figure 4.3: Distribution of religion of cancer patients receiving  
                          morphine drug 
 
Figure 4.4: Distribution of education of cancer patients receiving  
                    morphine drug 
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Table 4.1: Frequency and percentage distribution of  
                 demographic variables of cancer patients receiving                      
                  morphine drug in experimental and control group. 
N=30+30 
Demographic variables 
Group 
Experimental Control 
n % n % 
Occupation 
 
 
Unemployed 
Self employed 
Private employed 
Others  
7 
13 
7 
3 
24.3% 
45.7% 
24.3% 
9.7% 
12 
12 
 
4 
2 
40.3% 
40.3% 
12.7% 
6.7% 
Marital status Married 
Single 
Widow /widower 
 Divorced 
18 
8 
2 
2 
60% 
26.7% 
6.7% 
6.7% 
22 
4 
2 
2 
73.3% 
13.3% 
6.7% 
6.7% 
Family monthly income Below 10000 
10000-30000 
30000-50000 
Above 50000 
20 
6 
3 
2 
64% 
20% 
10% 
6% 
15 
10 
4 
1 
58.3% 
34.7% 
6% 
2% 
Type of family Nuclear family 
Joint family 
Extended family 
Others 
18 
8 
4 
0 
53.7% 
27% 
19.3% 
0% 
20 
5 
5 
0 
56.7% 
21.3 
22% 
0% 
Regarding occupation, 7(24.3%) were unemployed category 
,13(45.7%) were self employed category, 7(24.3%) were  private employed 
category  and 3(9.7%) were  others in experimental group. 12(40.3) were  
unemployed category, 12( 40.3) were self employed category, 4( 12.7) were  
private employed category  and 2(6.7%) were  others  in control group. 
Majority were self employed category in both group.  
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Considering marriage, 18(60%) were married, 8(26.7%) were single, 
2(6.7%) were widow/widower and 2(6.7%) were divorced in experimental 
group and 22(73.3) were married, 4(13.3%) were single, 2(6.7%) were 
widow/widower and 2(6.7) were divorced in control group. Majority were 
married category in both the group. 
Regarding family monthly income, 20(64%%) were below Rs10000  
category , 6(20%) were Rs10000-30000  income group, 3(10%) were Rs 
30000 to 50000  income group and 2(6%) were above Rs50000  income group 
in experimental group and 15( 58.3%) were below Rs10000 income group, 
10(34.7%) were Rs10000 to 30000 income group, 4(6%) were Rs30000 to 
50000 income group and  1(2%) were above Rs50000s income group. 
Majority were in the income group of below Rs10000 in both the group. 
Regarding type of family, 18(53.7) were belongs to nuclear 
family,8(27%) were belongs to joint family and  4(19.3%) were belongs to 
extended family in experimental group and 20  
(56.7%) were belongs to nuclear family and  5(21,3) were belongs to  joint 
family, 5(22%) were  belongs to extended family in control group. Majority 
were belongs to nuclear family category in both the group. 
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Figure 4.5: Distribution of occupation of cancer patients receiving  
morphine drug 
 
 
Figure 4.6: Distribution of marital status of cancer patients receiving 
morphine drug 
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Figure 4.7: Distribution of family monthly income of cancer patients  
receiving morphine drug 
 
 
 
Figure 4.8: Distribution of type of family of cancer patients receiving 
morphine drug 
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Table 4.1: Frequency and percentage distribution of  
                 demographic variables of cancer patients receiving   
                 morphine drug in experimental and control group.                                                                                            
N =30+30 
 
Demographic variables 
Group 
Experimental Control 
n % n % 
Habits  Alcohol  
Smoking 
Alcohol& 
smoking 
Others 
 
4 
2 
22 
 
4 
 
12.7% 
6 .3 % 
68.3% 
 
12.7% 
 
4 
6 
18 
 
4 
12.7% 
18.3% 
56.3% 
 
12.7% 
 
Support 
system 
Family  
Friends 
Relatives 
Neighbours  
20 
4 
3 
3 
66.7% 
13.3% 
10% 
10% 
 
18 
6 
4 
2 
 
64% 
16.7% 
13.3% 
6% 
Dietary 
pattern 
Vegetarian  
Non vegetarian 
4 
26 
 
13.3% 
86.7% 
 
2 
28 
6.7% 
93.3% 
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Regarding habits, 4(12.7%) were belongs to alcoholic alone, 2(6.3%) 
were belongs to smoking alone, 22(68.3) were belongs to alcoholic and 
smoking and 4(12.7%) were belongs to others category in experimental group. 
4(12.7%) were belongs to alcoholic alone, 6(18.3%) were belongs to smoking 
alone, 18(56.3%) were belongs to alcoholic and smoking and 4(12.7) were 
belongs to others category in control group. Majority were alcoholic and 
smoking in both the group.  
Considering dietary pattern, 4(13.3) were vegetarian, 26(86.7) were 
non vegetarian in experimental group and 2(6.7%) were vegetarian, 28(93.3) 
were non vegetarian in control group. Majority were non vegetarian in both 
the group. 
Regarding support system, 20(66.7%) were supported by family 
members, 4(13.3%) were supported by friends, 3(10%) were supported by 
relatives and 3(10%) were supported by neighbours in experimental group. 
18(64%) were supported by family members,6(16.7%) were supported by 
friends, 4(13.3%) were supported by relatives and 2(6%) were supported by 
neighbours in control group. 
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Figure 4.9: Distribution of habits of cancer patients receiving 
morphine drug 
 
 
 
Figure 4.10: Distribution of dietary pattern of cancer patients 
receiving morphine drug 
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Table 4.1: Frequency and percentage distribution of  
                 demographic variables of cancer patients receiving      
                 morphine drug in experimental and control group.                                                                                                                         
N=30+30 
 
Demographic variables 
 
Group 
Experimental Control 
n % n % 
History of bowel habits Daily regular pattern 
Passing hard stool 
regularly 
Passing stool 2-3 
times/week 
Others 
8 
14 
 
6 
 
2 
26.3% 
46.7% 
 
20.7% 
 
6.3% 
7 
15 
 
7 
 
1 
26.7% 
44.3% 
 
21% 
 
8%. 
Duration of consumption 
of morphine 
One month 
Two month 
Three month 
More than three 
month 
14 
9 
4 
2 
53.7% 
26.3% 
14% 
6% 
13 
6 
7 
4 
51.7% 
23.3% 
17% 
8% 
Fluid intake per day 1000ml 
1001ml-2000ml 
2000-3000ml 
>3000ml 
14 
7 
6 
3 
46.7% 
23.3% 
21% 
9% 
16 
8 
3 
3 
44% 
28% 
14% 
14% 
Regarding bowel habits, 8(26.3%) had daily regular pattern, 14(46.7) 
had passing hard stool regularly, 6(20.7) had passing hard stool 2-3 times per 
week, 2(6.3%) had others in experimental group and 7(26.7%) had daily 
regular pattern 15(44.3) had passing hard stool regularly, 7(21%) had passing 
hard stool 2-3 times per week, 1(8%) had others in control group. Majority 
were passing hard stool regularly in both the group.  
 42 
Considering duration of morphine consumption, 14(53.7%) were 
consuming morphine for one month, 9(26.3) were consuming morphine for 
two months, 4(14%) were consuming morphine for three months, 2(6%) were 
consuming morphine for more than three months in experimental group and 
13(51.7%) were consuming morphine for one month, 7(23.3) were consuming 
morphine for two months, 6(17%) were consuming morphine for three months,  
4(8%) were consuming morphine for more than three months in control group. 
Majority were in one month duration of morphine consumption category in 
both group.  
Considering habits of fluid intake, 14(46.7%) were consuming 1000ml 
per day, 7(23.3) were 1000-2000ml ,6(21%) were  2000-3000ml , 3(9%) were 
more than3000ml in experimental group and16(44%) were consuming1000ml 
per day , 8(28%) were 1000-2000ml ,3(14%) were 2000-3000ml and 3(14%) 
were  more than 3000 ml in control group. Majority of them were consuming 
1000ml per day in both group. 
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Figure 4.11: Distribution of bowel habits of cancer patients receiving 
morphine drug 
 
 
Figure 4.12: Distribution of duration of consumption of morphine 
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Figure 4.13: Distribution of fluid intake of cancer patients receiving 
morphine drug 
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SECTION B: ASSESSMENT OF PRE TEST LEVEL OF 
CONSTIPATION IN EXPERIMENTAL AND CONTROL 
GROUP. 
Table 4.2: Frequency and percentage distribution of pre test level of  
                 Constipation in experimental and control group. 
S. No Level of constipation 
Experimental group Control group 
n % n % 
 
1 
 
Characteristic 
Normal 0 0 0 0 
Mild 10 33.3 14 46.7 
Moderate 20 66.7 16 53.3 
Total 30 100 30 100 
 
2 
 
 
Pattern 
 
Normal 0 0 0 0 
Mild 10 33.3 14 46.7 
Moderate 20 66.7 16 53.3 
Total 30 100 30 100 
3  
Control 
 
Normal 0 0 0 0 
Mild 10 33.3 14 46.7 
Moderate 20 66.7 16 53.3 
  Total 30 100 30 30 
The table 4.2: depicts that 10(33.3%), 20(66.7%) has mild and 
moderate level of constipation in respect of Characteristics, Pattern, Control  
in experimental group respectively. 14(46.7%) , 16(53.3%) has mild and 
moderate level of constipation in respect of Characteristics, Pattern, Control 
in control group respectively.  
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SECTION B: COMPARISON OF PRE TEST LEVEL OF 
CONSTIPATION IN EXPERIMENTAL AND CONTROL 
GROUP. 
Table 4.2.1:  Comparison of mean and standard deviation of pre test  
level of constipation in experimental group and control 
group. 
 
S.No Components 
Group 
Student 
Independent 
t-test 
Experimental Control 
Mean SD Mean SD 
1 Characteristic 2.73 0.44 2.53 0.50 
 
t = 0.86  
p = 0.26 
Nil significant 
2 Pattern 2.66 0.47 2.53 0.50 
 
t = 0.86 
 p = 0.26 
Nil significant 
3 Control 2.66 0.47 2.53 0.50 
 
t = 0.86 
 p = 0.26 
Nil significant 
 
 
 
Total 
 
9.06 
 
1.06 
 
9.59 
 
0.94 
 
t= 2.58  
 p = 0.68 
The table 4.2.1 depicts that with respect to pre test the mean value 9.06 
with SD 1.06 of experimental group and the mean value of 9.59 with SD 0.94 
of control group projects” t” value  as 2.58  p=0.68 which is statistically not 
significant. Statistical significance was calculated by using student `s 
independent‟t‟ test. 
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Fig 4.14: Distribution of pre test level of constipation in experimental 
and control group. 
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SECTION C: ASSESSMENT OF POST TEST LEVEL OF 
CONSTIPATION IN EXPERIMENTAL AND CONTROL 
GROUP 
Table 4.3:  Frequency and percentage distribution of post test level of                 
Constipation in experimental and control group. 
S. No Level of constipation 
Experimental 
group 
Control group 
n % n % 
 
1 
 
 
 
Characteristic  
Normal  20 63 6 20 
Mild 6 22 12 39.50 
Moderate  4 15 12 39.50 
2  
 
Pattern  
Normal 20 63 6 20 
Mild  6 22 12 39.50 
Moderate  4 15 12 39.50 
3  
Control  
Normal 20 63 6 20 
Mild  6 22 12 39.50 
Moderate 4 15 12 39.50 
The table 4.3 depicted that 20(63%) had normal, 6(22%) had mild, 
4(15%) had moderate level of constipation in experimental group. 6(20%) had 
normal, 12(39.50%) had mild , 12(39.50%)  had moderate level of 
constipation in control group.  
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SECTION C: COMPARISON OF POST TEST LEVEL OF 
CONSTIPATION IN EXPERIMENTAL AND CONTROL 
GROUP 
Table 4.3.1  Comparison of mean and standard deviation of post test 
level of constipation of experimental and control group 
 
S.NO 
Post test level of 
constipation 
Groups 
Student 
Independent 
t-test 
Experimental Control 
Mean SD Mean SD 
1 Characteristic 0.40 0.20 2.53 0.50 t = 3.1  p = 
0.001 
2 Pattern 0.40 0.20 2.53 0.50 t = 3.1  p = 
0.001 
3 Control 0.40 0.20 2.53 0.50 t = 3.1 p 
0.001 
 Total 2.1 0.4 8.24 1.52 t=7.3  
p= 0.001 
significant   
The table 4.3.1 depicted that mean value of 2.1 with SD 0.4 in  
experimental group and mean value of 8.24 with SD1.52  in control group 
project “t” value as 7.3 which is statistically significant at p  = 0.001 level. 
Statistical significance was calculated by using student‟s  independent‟s‟ test. 
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Figure 4.15:  post test level of constipation in experimental and 
control group. 
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SECTION D: COMPARISON OF PRE TEST AND 
POST TEST LEVEL OF CONSTIPATION IN 
EXPERIMENTAL AND CONTROL GROUP 
Table 4. 4:  Comparison of mean and standard deviation of pre and 
Post test level of constipation in experimental and control  
group 
Group No of patients 
Pre test Post test Student’s 
Paired t-test 
Mean SD Mean SD 
Experimental  30 9.06 1.06 2.1 0.4 t= 12.2  
p= 0.001 
Control  30 9.59 0.94 8.24 1.52 t=1..38 p=0.48 
The table 4.4  depicted that with respect to Experimental group the 
mean value 9.06 with SD 1.06 of pre test and the mean value of 2.1 with SD 
0.4 of post test  project “t” value as 12.2 is statistically significant at P = 
0.001 level. 
As far as control group is concerned the mean value of 9.59 with SD 
0.94  of pre test and the mean value of 8.24 with SD 1.52 of post test project 
“t” value as 1.38 which is statistically not significant at p  = 0.48  
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SECTION  E: ASSOCIATION OF POST TEST LEVEL 
OF CONSTIPATION IN EXPERIMENTAL GROUP 
WITH THE SELECTED DEMOGRAPHIC 
VARIABLES 
Table 4.5:  Association of frequency distribution of post test level of 
constipation in experimental group with the selected 
demographic variables 
Demographic variables 
Level of constipation 
Chi 
square 
P value 
Characteristics, 
pattern, control 
Normal Mild 
n % n % 
 Alcohol 1 
1 
16 
 
3 
50 
50 
77.3 
 
60 
1 
1 
5 
 
2 
50 
50 
22.7 
 
40 
2.727 0.001 
Significant 
Habits Smoking 
Alcohol &smoking 
 
Others 
Dietary 
pattern 
Vegetarian 
Non vegetarian 
2 
22 
50 
84.6 
2 
4 
50 
18.4 
2.596 
 
0.001 
Significant 
Duration of 
morphine 
consumption 
One month 
Two months 
Three months 
More than three 
month 
18 
2 
2 
1 
83.3 
66.7 
66.7 
50 
4 
1 
1 
1 
16.7 
33.3 
33.3 
50 
0.833 0.001 
Significant 
The table 4.5 depicted that there was significant association of post test 
levels of constipation in experimental group with the selected demographic 
variables like dietary pattern, habits, duration of consumption of morphine. 
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Fig 4.16: Association of post test level of constipation with the                
Duration of consumption of morphine in experimental group 
 
 
 
Fig 4.17: Association of post test level of constipation with the  habits                 
in experimental  
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Fig 4.18: Association of post test level of constipation with the dietary 
pattern in experimental group. 
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DISCUSSION 
CHAPTER –5 
DISCUSSION  
   The study is aimed at assessing the effectiveness of aloe vera syrup 
in relieving morphine induced constipation among cancer patients in 
palliative care set up. Constipation is the common side effect of morphine.  
Constipation is an unpleasant and distressing symptom that many palliative 
care patients may experience, often having a profound effect on their quality 
of life. Adverse effect arising from constipation includes pain, bleeding from 
rectum, anemia, discomfort, psychological trauma. As research findings have 
the potential to streamline and rationalize practice atevery level, effectiveness 
of Aloe Vera syrup on constipation among cancer patients receiving morphine 
drug was assessed and findings were discussed below.   
In the study quasi experimental design was adopted and the result of 
study is discussed according to the objectives.  
The present study was carried on 60 cancer patients receiving 
morphine drug in selected palliative care centres at Chennai. Level of 
constipation was assessed with Victoria bowel performance scale. Aloe vera 
syrup was administered orally to experimental group in addition to routine 
measure (Duphalac syrup) and only routine measures were provided to control 
group. 
Results are discussed as follow: 
 Considering the age, 15(48%) were in experimental group and 14(46%) 
were in control group, were in the age group of 46-50.  
 As for gender, 16(53.3%) female were in experimental group and 
15(50%) female were in control group. It indicates that constipation is 
more prevalent among female cancer patients receiving morphine drug. 
 Regarding religion 13(43.3%) in experimental group and 18(60%) in 
control group were belongs to Hindu religion.  
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 In considering education 11(36.7S%) in experimental group were 
belongs to high school category , 4(42.3) in control group were coming 
under primary level of education category.  
 As for occupation 13(45.7) in experimental group, 12(40.3) in control 
group were belongs to self employed category. 
 Regarding family monthly income 20(64 %%) in experimental group, 
15(58.3%) in control group were coming under the category of below 
Rs 10000 income group. 
 Regarding habits 22(68.3) in experimental group, 18(56.3%) in control 
group were belongs to the category of smoking and alcohol.  
 With related to dietary pattern 26(86.7%) in experimental group and 
28(93.3) in control group were pertaining to the category of non 
vegetarian. 
 As for bowel movement concern 14(46.7%) in experimental group, 
15(44.3%) in control group were belongs to the category of passing 
hard stool regularly. 
 Regarding fluid intake 14(46.7%) in experimental group, 16(44%) in 
control group were coming under the category of consuming1000ml 
per day. 
 The findings of the study based on the objectives are: 
The first objective was to assess the pre test level of constipation 
among cancer patients receiving morphine drug in experimental  group 
and control group. 
Assessment of pre test level of constipation among cancer patients 
receiving morphine drug revealed that 10(33.3%) had mild level of 
constipation, 20(66.7) had moderate level of constipation in experimental 
group and none of them had normal bowel movement in this study. 
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Assessment of pre test level of constipation in control group revealed 
that14 (46.7) had mild level of constipation, 16(53.3) had moderate level of 
constipation and none of them had normal bowel movement in the pre -test. 
The mean and standard deviation of pre test level of constipation 
among cancer patients receiving morphine drug revealed that, the mean value 
9.06 with SD 1.06 in experimental group and the mean value of 9.59 with SD 
0.94 in control group project “t” value as 2.58 which is statistically not 
significant at p =0.68. 
Result of present study revealed that pre test level of constipation was 
high among cancer patients receiving morphine drug in both the group.  
The present study results were supported by a comparative study done 
by  Anton A.H.P. Megens, P et al (2013  on effect and side effect  of 
morphine and fentanyl. After administration of drugs, analgesia obtained at a 
peak effect dose of 0.032 mg/kg with fentanyl and 8.0 mg/kg with morphine. 
The result proved that morphine induced constipation in 45% of patients and   
Fentanyl induced constipation in 20% of patients  
The second objective was to assess the post test level of constipation 
among cancer patients receiving morphine drug in experimental group 
and control group.   
 The assessment of post test level of constipation in experimental 
group revealed that 20(63%) had normal level of bowel movement, 6(22%) 
had mild level of constipation and 4(15%) had moderate level of constipation. 
The assessment of post test level of constipation in control group 
revealed that 6(20%) had normal bowel movement, 12(39.50%) had mild level 
of constipation and 12(39.5%) had moderate level of constipation 
The mean and standard deviation of post test level of constipation in 
experimental and control group was that , mean value of  2.1 with SD 0.4 in 
experimental group and the mean value of 8.24 with SD 1.52in control group 
projects “ t” value as 7.3, which is statistically significant at p = 0.001 level.   
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The study result revealed that there was difference in the level of 
constipation score between experimental and control group. The present study 
revealed that experimental group has significantly lower score than control 
group. Lower score indicate lower level of constipation.  Hospital routine care 
was provided for both the group, in addition to routine care aloe vera syrup 
was administered to experimental group alone not to control group. This was 
the main reason for difference in the post test level of constipation score  
between two groups.  This study result proved that aloe vera was effective in 
relieving constipation.  
Ramesh PR et al (2013), showed similar result  in his study  by 
comparing the effect of liquid ( herbal) preparation ( aloe vere syrup) with a 
conventional laxative tablets ( sofsena) on  the opioid induced constipation  in 
advanced cancer patients.  There was no statistically significant difference in 
degree of laxative action between the two interventions. His study reported 
both the drugs had similar laxative action but aloe vera required only small 
volume to produce same effect and low cost make Misrakasneham( aloe vere) 
a good choice as prophylaxis among  opioid induced constipation. His study 
reported that aloe vera has similar laxative effect as convectional laxative . 
Present study result revealed that due to administrat ion of aloe vera 
syrup constipation level was reduced among experimental group than control 
group. 
The third objective was to compare the pre test and post test level of 
constipation among cancer patients receiving morphine drug in 
experimental and control. 
Analysis on comparison between pre test and post test level of 
constipation in experimental group revealed that, the mean value 9.06 with 
SD 1.06 of pre test and the mean value 2.1 with SD 0.4 post test project‟s‟ 
value as 12.2which is statistically significant at p 0.001. 
Analysis on comparison between pre test and post test level of 
constipation in control group depicted that , the mean value 9.59 with SD 0.94 
of pre test and the mean value 8.24 with SD 1.52 of post test project “ t” 
value as1.38 which is statistically not significant at p  = 0.48.  
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Comparison of mean and standard deviation of level of constipation in 
experimental and control group in the pre and post test revealed that there is 
significant difference in post test level of constipation score. In this present 
study result revealed that experimental group has significantly lower score than 
control group in the post test. This difference was mainly due to administration 
of aloe vera syrup to experimental group. This result concluded that aloe  vera 
syrup was effective in reducing level of constipation among cancer patients 
receiving morphine drug in experimental group. 
Post test mean value of Characteristic, pattern, control in experimental 
group were 0.40 with SD0.20 project “ t” value as 3.1 which is statistically 
significant at p = 0.001. 
Result of present study revealed that aloe vera syrup has equal effect 
on characteristic, pattern, control of bowel components.  
Hence the research hypothesis H1 stating that “There is a significant 
difference between pre test and post test level of constipation in experimental 
group” was accepted. 
This result was supported by Chapman and pittelli (2009) in his study, 
he administered a novel preparation containing Aloe vera, celandine for three 
days to cancer patients with opioid induced constipation. The result of his 
study  proved  aloe vera  improved  a range of constipation indicators (bowel 
movement frequency, consistency of stools, and laxative dependence).  Thus 
his study concluded that aloe vera was effective laxative in reducing 
constipation among cancer patients receiving morphine drug.    
The fourth objective was to associate the post test level of constipation 
among cancer patients receiving morphine drug in experimental group 
with the selected demographic variable. 
The association of post test level of constipation among cancer patients 
receiving morphine drug in experimental group revealed that there was 
significant association between the post test level of constipation and 
demographic variables like dietary pattern, habits and duration of 
consumption of morphine. There was no association between the post test 
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level of constipation with respect to other variables like  age, sex, education, 
occupation, religion, family monthly income, and support system, type of 
family, marriage, bowel habits, and fluid intake. 
Hence hypothesis H2 stating that “There is a significant association of 
post test level of constipation in experimental group with the selected 
demographic variables” was accepted when considering the demographic 
variables such  dietary pattern, habits, duration of consumption  of morphine. 
Whereas age, sex, education, occupation, religion, family monthly income, 
support system, type of family, marriage, bowel habits, fluid intake  were not 
accepted. 
The similar result was obtained by Jay K Udani (2013) in his study, 
conducted randomized, double-blind, placebo-controlled trial. One hundred 
thirty-eight cancer patients with various duration of morphine therapy 
reporting constipation were screened and 87 were randomized to placebo and 
product.  He measured bowel movement frequency, both average daily 
spontaneous bowel movements (SBM) and complete spontaneous bowel 
movements (CSBM). He administered aloe Vera syrup containing 
anthraquinone orally for one week. There was significant increases in 
spontaneous bowel movements at 4 th day, 5
th
  day, 6 th day, and  7
th
 day  in  
patient with one month therapy compared to  more than one month  therapy. 
When analyzed with demographic characteristics, duration of morphine 
consumption,  habits and dietary pattern showed a statistically significant 
difference in level of constipation before and after intervention.  
The present study results revealed that there was association with 
duration of consumption of morphine, dietary pattern and habits and post test 
level of constipation in the experimental group and it concluded that 
constipation was more common among cancer patients receiving morphine 
drug. Aloe vera was very effective in relieving constipation.  
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CHAPTER –6 
SUMMARY AND CONCLUSIONS, IMPLICATIONS, 
RECOMMENDATIONS AND LIMITATION 
6.1 SUMMARY 
This chapter includes a brief summary, the findings, conclusion, 
nursing implication and recommendations for further research.  
The study was conducted to determine the effectiveness of aloe vera 
syrup on constipation among cancer patients receiving morphine drug.  
Constipation is the commonest side effect of morphine. Patient with 
cancer receive morphine drug for pain. Adverse effect of morphine is 
constipation that will undermine the quality of life. Various types of treatment 
have been tried by the health personal to add comfort to the clients and free 
from pain and improve the quality of life. The present study was conducted to 
evaluate the effectiveness of Aloe Vera syrup on constipation among the 
cancer patients receiving morphine. 
The purpose of study were to reduce the constipation and improve the 
bowel movements  
A formal permission was obtained from Medical director of R M D 
Pain and Palliative care centres Chennai-600017.  The data was collected with 
the help of structured questionnaire and pre-test, post-test assessment method 
for a period of four weeks. 
The following objectives were set for the study: 
1) To assess the pre test level of constipation among cancer patients 
receiving morphine drug in experimental and control group.  
2) To assess the post test level of constipation among cancer patients 
receiving morphine drug in experimental and control group. 
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3) To compare the pre test and post test level of constipation among 
cancer patients receiving morphine drug in experimental and control 
group. 
4) To associate the post test level of constipation among cancer patients 
receiving morphine drug in experimental group with the selected 
demographic variable. 
Research hypotheses:  
H1: There is a significant difference between the pre-test and 
post-test level of constipation among cancer patients receiving morphine 
drug in experimental and control group. 
H2: There is a significant association in the post test level of 
constipation among cancer patients receiving morphine drug with the 
selected demographic variables. 
Review of literature  
The literature is divided into three section   
1) Literature related to Morphine use in Cancer Patients”.  
2) Literature related to morphine induced constipation”.  
3) Literature related to effectiveness of Aloe Vera”  
The conceptual framework adopted for the present study was Modified 
Ludwig Von Bertalanffy‟s General system theory-1968. This helped the researcher 
in approaching the problem in a comprehensive and systematic manner. Review of 
literature helped the researcher in the preparation of the conceptual model, tool 
and methodology of study.  
Quantitative evaluative approach was utilised to achieve the overall 
purpose. The research design used for the study was quasi experimental 
design. Sample was collected using non probability convenient sampling 
technique for the study and this continued till the desired size was met. The 
study was conducted in selected pain and palliative care centres at T.Nagar 
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and at Maduravoyul, Chennai - 600017. The sample consists of 60 cancer 
patients receiving morphine drug, 30 in experimental group and 30 in control 
group. 
With extensive review of literature, discussion with professional 
experts and with the investigator‟s personal  experience, structured 
questionnaire was used. It has two parts.  Part - 1 structured questionnaire to 
elicit demographic variables, Part - 2 Victoria bowel performance scale. 
Validity of tool was confirmed based on review of literature, and consultation 
and guidance from experts, reliability was confirmed by split half method.  
Pilot study was conducted to assess the feasibility, practicability, and 
also to determine the major flaws in the design. Prior permission was obtained 
from the Medical director RMD Pain and palliative care centres, Chennai.  
 6 members were selected who fulfilled the inclusion criteria. The 
administration of aloe vera syrup  had an appreciable effect in decreasing the 
level of constipation among cancer patients receiving morphine drug in 
experimental group. The tool was found feasible, no ambiguity found. 
The investigator collected data for four weeks. Formal approval was 
obtained from the Medical director of RMD Pain and Palliative care centres, 
Chennai. 
A total number of 60 cancer patients receiving morphine drug who met 
the inclusion criteria were selected by non probability convenient sampling 
technique. 
After getting the consent, pre test was done to assess the level of 
constipation in experimental and control group. The level of constipation was 
assessed by using Victoria bowel performance scale. Following the pre test 
with prescription of palliative care unit head aloe vera syrup 30 ml before 
breakfast in empty stomach was administered orally for 3 days to the 
experimental group in addition to routine care.  Only routine care was 
provided to control group. Post test level of constipation was assessed by 
using Victoria bowel performance scale on 3
rd
 day. Investigator maintained 
 64 
good interpersonal relationship with patients throughout the study and the 
patients were co-operated well.  
The major findings of the study were as follows 
The mean and standard deviation of pre test level of constipation 
among cancer patients receiving morphine drug in experimental  group and 
control group revealed that, the mean value 9.06 with SD 1.06 and the mean 
value of 2.1 with SD0.4 projects „t‟  as  2.58 which is not statistically 
significant at p  = 0.68   
The mean and standard deviation of post test level of constipation in 
experimental and control group depicted that, the mean value of 2.1 with SD 
0.4in experimental and mean value of 8.24 with SD 1.52 project„t‟ value as 
7.3 which is statistically significant at p 0.001 level.  
Analysis on comparison between pre test and post test level of 
constipation in experimental group revealed that the mean value of 9.06 with 
SD1.06 of pre test  and the mean value of   2.1with SD 0.4  of post test 
project „t‟ value as 12.2 which is statistically significant at p = 0.001 . 
Analysis on comparison between pre test and post test level of 
constipation in control group revealed that  the mean value 9.59 with SD 0.94 
of pre test and mean value 8.24 with SD1.52  of post test project  “t” value as 
1.38 which is statistically not significant at p = 0.48.  
Comparison of mean and standard deviation of level of constipation in 
experimental and control group revealed that there is significant difference in 
post test level of constipation score. The present study result revealed 
experimental group in post test has significantly lower score than control 
group. It concluded that the lower score in experimental group was mainly 
due to administration of aloe vera syrup. The result of present study proved 
that aloe vera was effective in reducing level of constipation among cancer 
patients receiving morphine drug in experimental group.  
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Post test mean value of Characteristic , pattern, control in experimental 
group 0.40 with SD 0.20 project “t” value as 3.1 which is statistically 
significant at p = 0.001. 
Aloe vera syrup has equal effect on characteristic, pattern, control of 
bowel components of Victoria bowel performance scale.  
The association of post test level of constipation in experimental group 
reveals that there was significant association found between the post test level 
of constipation and demographic variable like dietary pattern, habits, duration 
of consumption of morphine. There was no association found between the 
post test level of constipation with respect to other variables like  age, sex, 
education, occupation, religion, family monthly income, and support system, 
type of family, marriage, bowel habits, and fluid intake. 
6.2 CONCLUSION  
The study concluded that there was significant improvement in the 
bowel movement and softness of stool among cancer patients receiving 
morphine in experimental group compared with control group.  Result of 
present study concluded that aloe vera syrup had reduced the level of 
constipation and improved bowel movement in experimental group. More 
over it is cost effective, and not harmful can be used for large people. 
Comfort is more important to improve the quality of life.   
6.3 IMPLICATIONS OF THE STUDY 
The researcher had drawn the following implications from the study 
which is of vital concern in the field of Nursing education, Nursing practice, 
Nursing administration and Nursing research. 
NURSING PRACTICE 
 As a member of health team, Nurse plays a vital role in reducing 
constipation. 
 Nurses should create awareness and motivate others in the team to use 
aloe vera to reduce constipation among cancer patients receiving 
morphine drug. 
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 Educate the staff nurses about the effectiveness of aloe vera syrup to 
reduce constipation. 
 Nurses educate patients about the use and effect of aloe vera syrup.  
NURSING ADMINISTRATION  
 Nursing administrator or leaders should take interest in formulating 
principles and adopting various modalities of treatment for palliative 
care patients especially for patient with cancer receiving morphine 
drug for pain.  
 Through in service education programme, nurse can be motivated to 
learn and practice Aloe Vera syrup administration.  
 The nursing administrator should make arrangement for man power, 
material and money for utilization of this knowledge.  
 Evaluate the quality of nursing care by conducting regular clinical 
audit. 
NURSING RESEARCH 
 As a researcher, promote more research on reducing constipation among 
cancer patients receiving morphine drug in palliative care centre.  
 Disseminate the findings of the research through conferences, seminars 
and publishing in journal. 
 Promote effective utilization of research findings on management of 
constipation among cancer patients receiving morphine drug.  
 Further research studies can be conducted to enhance the knowledge in 
the field of nursing. 
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NURSING EDUCATION 
 Nursing curriculum is a mean through which future nurses are 
prepared.  
 A continuing nursing education programme can be arranged on 
morphine induced constipation and its effect on the quality of life.  
 Nurse educators should educate and motivate to use aloe vera syrup as 
a mode of therapy to reduce constipation among cancer patients.  
 Nurse educators should make use of available literatures and studies 
related to measures of improving bowel movement.  
 Nurse educators should encourage the student for effective utilization 
of research based practice. 
 Periodic conferences, seminars, symposium etc., can be arranged on 
Aloe Vera syrup.  
6.4 RECOMMENDATIONS 
 Same study can be done with large sample so that the result can be 
generalized. 
 Same study can be done on different setting.  
 Comparative study can be taken between community and hospital.  
6.5 LIMITATIONS 
 The investigator found difficulty in getting adequate literature 
related to the study especially in India. 
 Due to time constrains, the investigator was unable to take large 
sample for study. 
 The study was limited to the time duration of one month.   
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TOOL USED FOR DATA COLLECTION 
PART 1: To assess demographic Variables 
PART 2: Victoria bowel performance scale 
PART – 1 
  Sample Number 
 1. Age in years         
1. 36-40  
2. 41-45  
3. 46-50  
4. 51-55   
2. Gender 
1. Male                                            
2. Female                                            
3. Religion 
1. Hindu                                          
2. Muslim                                         
3. Christian                                           
4. Others                                             
4. Educational status 
1. Illiterate                                       
2. Primary school                              
3. High school                                    
4. Higher secondary 
5. Graduate  
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5. Occupation 
1. Unemployed                                   
2. self employed                              
3. private employed 
4. Others                                           
6. Marital status 
1. Married                                          
2. Un Married                                    
3. Widow/Widower                            
4. Divorced   
7. Family Monthly income 
1. Below Rs.10000/-                             
2. Rs.10001/- to Rs.30000/-                  
3. Rs.30001/- to Rs.50000/-                  
4. Above Rs.50000/-                            
8. Type of family 
1. Nuclear family                               
2. Joint family                                    
3. Extended family                              
4. Others                                             
9. Habits  
1. Alcohol  
2. Smoking                                      
3. Alcohol and Smoking                                          
4.  Tobacco.   
5. other (if any specify) 
10. Support System 
1. Family  
2. Friends 
3. Relatives 
4. Neighbors 
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11 .Dietary Pattern 
1. Vegetarian 
2. Non Vegetarian 
12. Duration of consumption of Morphine 
1. One Month 
2. Two Months 
3. Three Months 
4. More than Three Months 
13) History of bowel Habits 
1.  Daily regular pattern 
2. Passing hard stool regularly 
3.  Passing stool 2 -3 times per week 
4. if any other ( specify) 
14) Fluid intake per day (ml) 
1. < 1000ml 
2.  1001  - 2000ml 
3. 2001ml – 3000ml 
4. 3000ml 
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GUIDELINE FOR ADMINISTRATION OF ALOE 
VERA SYRUP FOR CONSTIPATION 
CONSTIPATION: 
 Constipation is the symptom of gastro intestinal disorder or side effect 
of certain medicine. It is distressing symptom that affects the quality of life. 
Constipation is the problem for many people today. Constipation is the 
commonest side effect of morphine drug which is the main drug for the 
treatment of cancer pain. Morphine is commonly used in palliative care centre 
for the symptomatic treatment of cancer to enhance the quality of life. Aloe 
vera is one of natural product that is used as laxative that can be used for 
morphine induced constipation. 
  Definition of Aloe vera syrup 
It refers to commercially prepared one, 30 ml per day before food in 
the empty stomach for 3 days. 
PURPOSE 
1. To improve bowel movement 
2. To softness the stool 
3. To decrease level of constipation 
ARTICLE REQUIRED 
1. 30 ml ounce glass 
2. Kidney tray 
3. Aloe vera syrup 
4. Towel  
5. 50 ml syringe in case ryles tube feeding 
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S. 
No 
Procedure Scientific Principle 
1.  Explain the procedure Explanation alleviates anxiety and 
promotes rapport. 
2.  Assemble the equipment Organization will increase the efficiency 
3.  Position the patient as per 
their comfort. 
It promote comfort for the patient 
4.  Protect the patient by 
placing towel over chest 
 
To prevent soiling of dress and bed. 
5.  Wash hands and wear 
gloves 
Prevent cross infection and promote 
hygienic practice. 
6.  Administer aloe vera syrup 
30 ml orally for  three days. 
Anthraquinone in aloe vera will act on the 
gut and increase the bowel movement and 
reduce the reabsorption of water in large 
intestine from stool. 
7.  Observe for any adverse 
reaction of aloe vera syrup. 
Help to decide whether to continue or stop 
the administration of aloe vera syrup. 
8.  Replace the article. Proper placement helps in easy access.  
9.  Wash hands. To prevent cross infection. 
10.  Record the procedure and 
level of constipation, 
Documentation provides additional means 
for evaluating care and outcomes. 
 
VICTORIA BOWEL PERFORMANCE SCALE 
 
-1, 0, +1  : Normal     -2   : Mild Constipation 
-3   : Moderate Constipation   -4   : Severe Constipation 
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CONSENT FORM 
STUDY TITLE: 
A study to assess the effectiveness of Aloe Vera syrup on constipation 
among cancer patients receiving morphine drug in selected palliative care 
centres, at Chennai. 
INVESTIGATOR:  Mrs.Sudha.P 
In signing this document, you are giving consent to be interviewed by 
Mrs.Sudha.P, M.Sc Nursing student of Venkateswara Nursing College , 
Thalambur, Chennai District. You will be a part of the research study 
mentioned above. 
This consent is entirely voluntary and even during any part of the study 
you can refuse to answers any specific questions or to decide to terminate at 
any point. Your answers will not be given to anyone else and no respect of the 
study will ever identify you in anyway. 
I have been explained and made understood the need and importance of 
this consent forms and voluntary consent to participate in this study.  
Subject’s Signature 
I have explained this study to the above subject and have sought her 
understanding for informed consent.  
 
Investigator’s Signature 
 
 
 
 CERTIFICATE OF ENGLISH EDITION 
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This is to certify that the dissertation work “A study to assess the 
effectiveness of Aloe Vera syrup on constipation among Cancer 
patients receiving Morphine drug in selected Palliative Care Centres 
at Chennai” done by Mrs.Sudlia.P, M.Sc Nursing II year student, 
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appropriate. 
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Venkateswara Nursing College, 
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Sub: Permission to conduct the study 
**** 
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